ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,126.92
0.38%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) Noticias

BIAF bioAffinity Technologies Inc

2.08
-0.21 (-9.17%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
bioAffinity Technologies Inc BIAF NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.21 -9.17% 2.08 18:57:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.24 2.03 2.2511 2.09 2.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:00BWbioAffinity Technologies News Update
24/4/202407:00BWbioAffinity Technologies Advances New Product Development..
09/4/202407:00BWbioAffinity Technologies Expands Campaign to Support..
01/4/202408:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
08/3/202416:00EDGAR2Form 8-K - Current report
08/3/202412:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
08/3/202411:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
08/3/202411:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/3/202420:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/3/202409:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
06/3/202408:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
05/3/202416:26EDGAR2Form 8-K - Current report
05/3/202407:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
21/2/202407:00BWbioAffinity Technologies News Update
06/2/202407:00BWMedical Director of Lung Innovations Network and The Lung..
02/2/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:05EDGAR2Form 8-K - Current report
30/1/202407:00BWbioAffinity Technologies In The News
24/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202407:00BWbioAffinity Technologies Announces Award of Therapeutic..
08/1/202407:00BWbioAffinity Technologies In the News
08/12/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202307:45EDGAR2Form 8-K - Current report
05/12/202307:00BWbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its..
30/11/202308:20EDGAR2Form 8-K - Current report
30/11/202307:00BWCMS Posts Final Payment Determination for bioAffinity..
28/11/202315:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202307:00BWbioAffinity Technologies VP David Elzi, Ph.D., Named to..
27/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
16/11/202316:23EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202316:07EDGAR2Form 8-K - Current report
15/11/202307:00BWbioAffinity Technologies Teams with American Cancer Society..
14/11/202315:01BWbioAffinity Technologies Reports Third Quarter 2023..
14/11/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202307:00BWbioAffinity Technologies Names Dallas J. Coleman as National..
03/11/202315:49EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202315:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/10/202316:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202316:27EDGAR2Form 8-K - Current report
10/10/202307:00BWbioAffinity Technologies to Present at the 8th Annual Dawson..
10/10/202305:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/9/202315:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/9/202316:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
20/9/202316:29EDGAR2Form S-1 - General form for registration of securities under..

Su Consulta Reciente

NASDAQ
BIAF
bioAffinity Technologies
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados